Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001104659-25-009678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | OBIO | Cleary Chris | Dir | A - Grant | $0.00 | +10.2K | 10.2K | New | $0 |
| D | 2025-02-05 | 2025-02-03 | OBIO | Cleary Chris | Dir | A - Grant | $0.00 | +30.7K | 30.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2025-02-03 | A | A | 10,155 | $0.00 | 10,155 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on February 3, 2025. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 2,987 RSUs vest on June 24, 2025 and (2) the remaining 7,168 RSUs vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such dates. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | A | A | 30,742 | $0.00 | 30,742 | D | $5.58 · — to 2035-02-03 | 30,742 Common Stock | (F2) The stock options shall vest as follows: (1) 9,223 stock options shall vest on June 24, 2025 and (2) the remaining 21,519 stock options shall vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such date. |